-+ 0.00%
-+ 0.00%
-+ 0.00%

Samsung Biologics shares fell 7.1% after the company announced a $2.2 billion share sale plan.

Zhitongcaijing·08/28/2026 00:09:04
Listen to the news
Samsung Biologics shares fell 7.1% after the company announced a $2.2 billion share sale plan.